glutathione and warfarin

glutathione and warfarin Structural basis of antagonizing the vitamin K catalytic cycle for anticoagulation A genome-wide CRISPR-Cas9 knockout screen

Name: glutathione and warfarin Structural basis of antagonizing the vitamin K catalytic cycle for anticoagulation A genome-wide CRISPR-Cas9 knockout screen
Brand: ldesquadrias.com.br
SKU: 12514659271
Price: 23.56 USD
Availability: InStock
Rating: 4.4572 (7 reviews)

A genome wide CRISPR Cas9 knockout screen identifies FSP1 as the warfarin resistant vitamin K reductase Nature Communications Structural and cellular basis of vitamin K antagonism ScienceDirect All About Warfarin Mechanism of Action Structural and cellular basis of vitamin K antagonism Journal of Thrombosis and Haemostasis Warfarin induced gastrointestinal bleeding with : Medicine Characterization of Warfarin Inhibition Kinetics Requires Stabilization of Intramembrane Vitamin K Epoxide Reductases ScienceDirect

SKU: 12514659271 · From ldesquadrias.com.br

4.5

USD23.56 USD73.56

Pay in 4 interest-free payments of $5.89 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 4 - Aug 9

Description

What is BPC 157 and how does it work

It is supplied as a lyophilized peptide powder for laboratory research and analytical applications

TB-500 for recovery from overuse injuries

Dihexa (chemical name N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, development code PNB-0408) is a synthetic peptide derived from angiotensin IV, originally developed by researchers at Washington State University as a potential therapy for Alzheimer's disease